In this review:
Ten areas of clinical relevance in advanced prostate cancer
Locally advanced prostate cancer
Biochemical recurrence (BCR) of prostate cancer after local therapy
Management of the primary tumour in the metastatic setting
Management of newly diagnosed metastatic hormone-sensitive prostate cancer (mHSPC), including oligometastatic prostate cancer
Management of nonmetastatic (M0) castration-resistant prostate cancer (CRPC)
Management of metastatic CRPC (mCRPC)
Bone health and bone metastases
Molecular characterisation of tissue and blood
Interpatient heterogeneity
Side-effects of hormonal treatments and their management
Please login below to download this issue (PDF)